Jasenka Piljac Žegarac, PhD

Jasenka is a scientist and professional freelance medical writer with expertise in a wide range of therapeutic and scientific areas. Her research articles have gathered more than 1200 citations. At The Scientist Writer LLC, she helps clients from the food, pharma, and biotech industries develop top-quality communications solutions. Find Jasenka on LinkedIn.

Most Recent Articles by Jasenka Piljac Žegarac, PhD

Universal Influenza Vaccine: A Game Changer in Prevention

Universal Influenza Vaccine: A Game Changer in Prevention

By

A dedicated research effort led by NIH's National Institute of Allergy and Infectious Diseases is aimed at developing a universal influenza vaccine that would confer better and longer-lasting protection against influenza virus strains.

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

By

Without proactive measures and response, the changing climate is projected to continue to adversely affect the global incidence and distribution of infectious diseases and cause 250,000 additional deaths per year between 2030 and 2050.

MicroRNAs in Infectious Disease: Emerging Clinical Applications

MicroRNAs in Infectious Disease: Emerging Clinical Applications

By

MicroRNAs are currently under investigation for various clinical applications in infectious disease because of their role in host response to infection and effects on innate and adaptive immune pathways.

Racial Disparities in HCV Incidence and Treatment Outcomes

Racial Disparities in HCV Incidence and Treatment Outcomes

By

Racial disparities in HCV treatment outcomes can be partially explained by the differences in underlying immune/genetic characteristics of patients.

Preventing HCV Transmission: Utility of Needle/Syringe Programs

Preventing HCV Transmission: Utility of Needle/Syringe Programs

By

Needle/syringe programs (NSPs) have proven to be effective and moderately effective in preventing transmission of HCV infection and minimizing drug-related harms among people who inject drugs in Europe and North America, respectively.

More Articles by Jasenka Piljac Žegarac, PhD

Sign Up for Free e-newsletters